. Author manuscript; available in PMC: 2013 Jun 30.

Published in final edited form as: Nitric Oxide. 2012 Mar 14;27(1):1–8. doi: 10.1016/j.niox.2012.02.004

Table 2.

Effect of NaNO₂ treatment 3mg/kg ip daily for 21 days on monocrotaline induced right ventricular hypertrophy

	RV/LV+S (grams)	RV/Total Heart (grams)
Control	221 ± 14	187 ± 11
Monocrotaline (day 28)	473 ± 32^*	336 ± 11^*
Monocrotaline + NaNO₂ 3mg/kg ip (day 35)	319 ± 34^*^⧧	272 ± 11^*^⧧

Values are expressed as mean ± SE.

denotes a P value < 0.05 when compared to control,

^⧧

denotes a P value < 0.05 when compared to placebo.

n = 10, 7, and 11 for control, monocrotaline and monocrotaline + NaNO₂ groups respsectively.